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Abstract
Purpose To determine the prevalence of inhalant use in Russian adolescents and to investigate associated psychosocial 
problems from a gender perspective.
Methods Data on inhalant use and comorbid psychopathology were collected by means of self-reports from 2892 (42.4% 
boys) sixth to tenth grade students in public schools in Arkhangelsk, Russia. Multivariate analysis of covariance was used 
to assess differences in the levels of internalizing and externalizing problems in boys and girls, who were non-users and 
users of inhalants.
Results The prevalence of inhalant use was 6.1% among boys and 3.4% among girls. Compared with non-users, inhalant 
users scored significantly higher on internalizing and externalizing problems, functional impairment and lower on academic 
motivation, with psychopathology increasing with age. While there were no gender differences for internalizing problems, 
increased levels of externalizing problems in inhalant users were gender-specific (significantly higher in boys).
Conclusions Inhalant use is related to significantly higher levels of comorbid psychopathology in Russian adolescents. Com-
prehensive, evidence-based prevention and intervention policies are needed to address inhalant use and its harmful effects.
Keywords Inhalant use · Adolescents · Mental health
Introduction
Substance use is common among adolescents [1, 2]. Among 
substances, inhalants (household and industrial chemicals) 
occupy a special place because they are relatively inexpen-
sive and readily available. Inhalants are often among the 
first and most commonly used substances aside from alcohol 
and cigarettes [3]. Inhalant use often starts at an early age, 
in almost half of the cases, before 13 years of age, and in 
over 80% of users before age 15 [4]. Research suggests that 
inhalant use rates peak during the mid-teenage years, with 
the rate of use among 14 year olds (3.4%) being nearly twice 
that of 12 year olds (1.8%) [5].
Inhalants are also among the most dangerous types of 
drugs abused by children and adolescents, as they are highly 
addictive both physically and psychologically [6, 7] and 
there is a substantial risk of a permanent impact on men-
tal and physical functioning [8]. Even experimental use of 
inhalants has been linked to adolescent risk-taking and dis-
ruptive behaviors [9, 10], whereas the chronic use may lead 
to more serious and long-lasting mental and somatic health 
problems [11, 12]. Studies of adolescent inhalant users have 
found that they are more likely than non-users to report poor 
family relations, disrupted living situations, academic prob-
lems [13, 14] and are at increased risk of multiple drug use 
[13]. Furthermore, inhalant use has been linked to higher 
rates of anxiety and depression [7], suicidal thoughts and 
attempts [15, 16], as well as to delinquency [17].
Despite extensive research on youth inhalant use in the 
United States [4, 18], very few large-scale studies have been 
conducted to date on this phenomenon in countries outside 
the US. In Europe, the reported rates of ever using inhalants 
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for students aged 15–16 years old have varied widely from 
3% in Bulgaria to 18% in Ireland [19]. Data from the Euro-
pean School Survey Project on Alcohol and Other Drugs 
(ESPAD) showed that in Russia the prevalence of inhal-
ant use in the general adolescent population was 9% [20]. 
However, other reports suggest a higher figure, for example, 
statistics from the Russian Ministry of Education showed 
that 16% of adolescents and young adults used inhalants 
regularly (2–3 times a week) [21].
Considering the lack of large-scale epidemiological data 
and a high discrepancy in the reported figures, more research 
is needed to obtain a clearer picture of the situation regard-
ing inhalant use and its effects in Russian adolescents. In 
addition, given the substantial gender differences in the 
prevalence of internalizing and externalizing problems in 
adolescents [22], it is possible that the use of inhalants may 
be associated with different types of problems in boys and 
girls. Hence, this study had two main aims, namely, (1) to 
assess the general prevalence of inhalant use in Russian ado-
lescents, and (2) to investigate the psychosocial problems 




Data were drawn from a survey undertaken as part of the 
Social and Health Assessment (SAHA) research project 
[23, 24]. The survey was conducted in the northwestern 
Russian city of Arkhangelsk. Data were collected from a 
representative sample of students (age 12–17) in the city’s 
public schools (i.e. 10% of students in each of the city’s 
four districts). The subjects were selected from schools that 
were randomly selected from a list of all the city’s schools, 
and from within classes randomly selected from within each 
school. All invited students completed the survey question-
naire anonymously in their classrooms in the presence of 
teachers during a normal school day. Written informed 
consent was obtained before the questionnaire was admin-
istered and children had the right to refuse to participate in 
the study. The recruited sample comprised 2892 students 
(42.4% boys) with a refusal rate of 3.6%. Ethical approval 
for the study was obtained from the Northern State Medical 
University in Arkhangelsk, Russia.
Measures
Items from the SAHA survey questionnaire were used in the 
study. The survey included new scales that were developed 
specifically for the SAHA study and scales that had been 
used previously with similar populations [25, 26]. In the 
current study, the following measures were used.
Inhalant use
The students were asked to indicate how often they used 
huffing (glue, aerosols) to get high on a 5-point response 
scale (“Never”, “1–2 times a year”, “1–2 times a month”, 
“1–2 times a week”, and “Every day”). The respondents 
were then divided into users and non-users.
Internalizing problems
Depressive symptoms were assessed using an adaptation 
of the Center for Epidemiologic Studies Depression Scale 
(CES-D) [27] consisting of ten items (e.g. “I felt really 
down”). Respondents reported on the presence of depres-
sive symptoms during the past month on a three-point scale 
[“Not true” (scored 0); “Somewhat true” (1); or “Certainly 
true” (2)]. The total score ranged from 0 to 20 with higher 
scores indicating increased depressive symptoms (Cron-
bach’s α for the scale = 0.80).
Anxiety symptoms were assessed with 12 items [23] 
describing worrisome, preoccupying thoughts or unpleas-
ant feelings about oneself or external stimuli (e.g. “I worry 
about other people liking me”). Students reported on the 
presence of anxiety symptoms on a three-point scale [“Not 
true” (scored 0); “Somewhat true” (1); or “Certainly true” 
(2)]. The total score ranged from 0 to 24 with higher scores 
indicating increased anxiety symptoms (α = 0.87).
Posttraumatic stress symptoms were assessed with the 
Child Post-Traumatic Stress-Reaction Index (CPTS-RI; 
[28]), a self-report questionnaire that contains 20 items 
with a Likert-type response scale assessing the frequency of 
symptoms ranging from “Never” (0), to “Most of the time” 
(4). The CPTS-RI total score (ranging from 0 to 80) has 
been found to correspond highly with the clinical diagnosis 
of PTSD [29] (α = 0.85).
Impact Supplement of the Strength and Difficulties Ques-
tionnaire (SDQ) [30] is a brief screening questionnaire that 
asks whether the respondent (1) thinks that he/she has dif-
ficulties in emotions, concentration, behavior, or in getting 
along with other people (ranging on a 4-point scale from 
“No” to “Yes, severe difficulties”), and (2) if so, about the 
perceived degree of distress (“Do these difficulties upset or 
distress you?”); of social impairment (“Do these difficulties 
interfere with your everyday life?” in four areas: home life, 
friendships, classroom learning, and leisure activities); and 
of burden to others (“Do these difficulties make it harder for 
those around you?”). Responses for distress, social impair-
ment, and burden to others ranged on a 4-point scale from 
“Not at all” (0) to “A great deal” (3). A total impact scale 
score was calculated by summing up the six items, covering 
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perceived distress, social impairment in 4 different domains 
and burden to others. In cases in which the response was 
‘No’ to the first impact question, the whole impact score was 
set to zero (α = 0.73).
Externalizing problems
Alcohol use was assessed with three items derived from the 
Monitoring the Future Scale [31] that quantified the use of 
three alcoholic beverages (beer, wine, and hard liquor) dur-
ing the last 30 days (using a 4-point scale, ranging from “0” 
to “6 or more times”) (α = 0.88).
Marijuana use was assessed with a single question, ask-
ing the respondent to indicate the frequency of use during 
the last 30 days (using a 4-point scale, ranging from “0” to 
“6 or more times”).
Problems related to alcohol use [23]. This 11-item scale 
asks whether the respondent had problems in the past year 
related to drinking, such as getting into fights, having money 
problems, damaged friendships, etc. All items are answered 
on a 4-point scale ranging from “0” to “6 or more times” 
(α = 0.74).
Problems related to substance use [23]. This scale con-
sists of five items, asking whether the respondent ever had 
problems related to the use of drugs, such as getting into 
an argument, feeling sick, getting arrested, etc. The items 
are rated on a 3-point scale (from “Never” to “Often”). The 
total score ranged from 0 to 10 with higher scores indicating 
increased problems (α = 0.72).
Antisocial Behavior Scale [32]. This includes three 
subscales assessing behavior problems of different sever-
ity. Respondents are asked to report on a 5-point scale how 
many times (ranging from “0” to “5 or more times”) they 
were involved in the following behaviors during the past 
year. (1) Conduct Problems. Includes six items describing 
mild behavior problems, such as lying to a teacher or a par-
ent, staying out all night without permission, shoplifting, 
etc. The total score ranged from 0 to 24 with higher scores 
indicting greater problems (α = 0.78). (2) Less Severe Delin-
quency. This subscale consists of five items describing non-
violent antisocial behavior, such as stealing a motorcycle/
car, pick-pocketing etc. The total score ranged from 0 to 20 
with higher scores indicating greater delinquency (α = 0.75). 
(3) Severe Delinquency. This consists of five items, pertain-
ing to relatively serious aggressive and antisocial behav-
iors, i.e. starting a fistfight, being arrested by the police, 
etc. Students were asked to report on a 5-point scale how 
many times they had been involved in each type of antisocial 
behavior during the past year (from 0 = zero times to 4 = five 
or more times). The total score ranged from 0 to 20 with 
higher scores indicating higher levels of severe delinquency 
(α = 0.78).
Academic Motivation Scale [33, 34]. This included six 
items describing the perceived importance of academic 
achievement and academic motivation (e.g. “It is important 
to me to be considered a bright student by my teachers”). 
The items are rated on a 4-point scale, ranging from “Defi-
nitely not true” (1) to “Definitely true” (4). The total score 
ranged from 6 to 24 with higher scores indicating higher 
levels of academic motivation (α = 0.84).
Affiliation with delinquent peers For this 9-item scale 
developed by the SAHA Research Evaluation Team [23], 
respondents are asked how many of their close friends (from 
“None” to “Most or all”) are involved in different types of 
delinquent behavior such as dropping out of school, smoking 
cigarettes, drinking alcohol, etc. The summed score could 
range from 9 to 36 with higher scores indicating higher lev-
els of affiliation with delinquent peers (α = 0.76).
Statistical analysis
Multivariate analysis of covariance (MANCOVA) was used 
to assess differences in the levels of internalizing and exter-
nalizing conditions/behaviors in boy and girl users and non-
users of inhalants. Hence, we used a 2 (inhalant use) by 2 
(gender) design conducted for internalizing and externaliz-
ing problems separately to diminish the number of variables 
in the analysis and to avoid multiple comparisons. Because 
age influences children’s development and is associated with 
the outcome variables in this study, all analyses were con-
ducted while controlling for age. The unique contribution 
of each of the two fixed factors (inhalant use and gender), 
the covariate (age), and the one interaction term (inhalant 
use × gender) was assessed through post hoc between-subject 
tests and unstandardized parameter estimates derived from 
the MANCOVA. Results are presented as means (M) and 
standard deviations (SD), and for individual outcomes, as 
partial eta squared (η2), a common metric of effect size that 
represents the unique amount of variance explained by each 
predictor variable.
Results
The prevalence of inhalant use was 6.1% (n = 69) among 
boys and 3.5% (n = 55) among girls. Of these, 3.6% (n = 41) 
of boys and 2.4% (n = 39) of girls used inhalants irregu-
larly, while 2.5% (n = 28) of boys and 1.0% (n = 16) of girls 
reported using inhalants several times a week. Given the 
relatively low prevalence rates, both the irregular and regu-
lar inhalant user groups were combined into a single users 
group, which was then compared to the non-users group.
Tables 1 and 2 present descriptive statistics [M (SD)] 
from the MANCOVA regarding differences in internalizing 
and externalizing problems, respectively, by boys’ and girls’ 
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inhalant use. Compared with non-users, inhalant users of 
both genders scored significantly higher on depression, post-
traumatic stress, functional impairment and lower on aca-
demic motivation. Inhalant users also had higher scores on 
alcohol and marijuana use, alcohol and substance use-related 
problems, conduct problems, delinquency and reported a 
higher affiliation with delinquent peers.
Tables 3 and 4 present effect sizes for each dependent var-
iable, as well as the summary statistics. With regard to inter-
nalizing problems (Table 3), the main effect for inhalant use 
(η2 = 0.026, p < 0.001) was significant, suggesting increasing 
levels of internalizing psychopathology in inhalant users. 
The main effect for gender (η2 = 0.002, p > 0.05) was not 
significant, which indicates that there were no gender differ-
ences in relation to internalizing problems. The interaction 
effect for inhalant use × gender was not significant for any 
of the internalizing variables, except for posttraumatic stress 
(η2 = 0.002, p < 0.05), which means that the overall general 
pattern of internalizing problems in relation to inhalant use 
did not differ between boys and girls. Finally, the main effect 
for age was significant (η2 = 0.024, p < 0.001), suggesting 
that the levels of internalizing problems increased with age. 
The post hoc univariate effects for internalizing problems 
in relation to inhalant use were significant for depressive 
symptoms (η2 = 0.008, p < 0.001), and posttraumatic stress 
(η2 = 0.011, p < 0.001), but not for anxiety (η2 = 0.000, 
p > 0.05). The post hoc univariate effects in relation to 
inhalant use were also significant for academic motivation 
(η2 = 0.007, p < 0.001) and SDQ impairment (η2 = 0.016, 
p < 0.001) which indicates poorer school achievement and 
increasing difficulties with emotions, concentration and a 
higher degree of distress in inhalant users.
Table 1  Internalizing problems 
scores [M (SD)] by gender in 
relation to inhalant use
M mean, SD standard deviation
Variable Non-users (n = 2595) Users (n = 124)
Boys (n = 1070) Girls (n = 1525) Boys (n = 69) Girls (n = 55)
Depression 4.95 (3.91) 6.60 (4.21) 7.50 (5.35) 7.75 (4.33)
Anxiety 12.22 (5.82) 14.11 (5.52) 13.22 (4.77) 13.19 (5.43)
Posttraumatic stress 17.42 (10.78) 21.33 (11.38) 25.70 (15.66) 24.60 (13.65)
Academic motivation 17.03 (3.10) 17.48 (2.93) 16.08 (2.69) 15.88 (3.40)
SDQ functional impairment 0.69 (1.43) 0.92 (1.62) 1.78 (2.51) 1.85 (2.39)
Table 2  Externalizing problems 
scores [M (SD)] by gender in 
relation to inhalant use
M mean, SD standard deviation
Variable Non-users (n = 2499) Users (n = 95)
Boys (n = 991) Girls (n = 1508) Boys (n = 47) Girls (n = 48)
Alcohol use 4.37 (3.08) 4.35 (2.98) 6.85 (2.82) 6.35 (2.46)
Alcohol-related problems 1.22 (1.82) 0.93 (1.48) 4.11 (2.82) 2.67 (2.08)
Marijuana use 0.24 (0.84) 0.14 (0.53) 1.87 (2.15) 1.04 (1.80)
Substance use-related problems 0.12 (0.55) 0.06 (0.41) 2.49 (2.77) 1.60 (2.58)
Conduct problems 4.80 (4.82) 4.20 (4.43) 10.19 (5.77) 9.00 (5.44)
Less severe delinquency 0.98 (2.59) 0.38 (1.26) 8.77 (9.65) 3.65 (6.26)
Severe delinquency 2.59 (3.85) 0.72 (1.85) 9.17 (7.88) 4.46 (5.16)
Affiliation with delinquent peers 18.71 (6.06) 17.28 (5.66) 25.11 (7.07) 25.21 (6.84)
Table 3  Effect sizes for internalizing dependent variables (η2, p) and summary statistics (Wilks’ lambda, F(df), η2, p)
Depression Anxiety Posttraumatic stress Academic motivation SDQ impairment Summary statistics
Age 0.013, < 0.001 0.001, ns 0.001, ns 0.006, < 0.001 0.009, < 0.001 0.976, 13.02 (5, 2595), 
0.024, < 0.001
Inhalant use 0.008, < 0.001 0.000, ns 0.011, < 0.001 0.007, < 0.001 0.016, < 0.001 0.974, 13.78 (5, 2595), 
0.026, < 0.001
Gender 0.002, < 0.05 0.001, ns 0.001, ns 0.000, ns 0.000, ns 0.998, 1.24 (5, 2595), 0.002, 
ns
Inhalant use by gender 0.001, ns 0.001, ns 0.002, < 0.05 0.000, ns 0.000, ns 0.997, 1.66 (5, 2595), 0.003, 
ns
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For externalizing problems (Table 4), the main effect for 
inhalant use was significant (η2 = 0.253, p < 0.001), sug-
gesting higher levels of externalizing problems in inhal-
ant users (see Table 2 for means and SDs). However, the 
associations were much stronger, with externalizing prob-
lems explaining 25% of the variance in inhalant use (as 
opposed to the 3%, explained by internalizing problems). 
Here, we also observed a significant main effect for gender 
(η2 = 0.061, p < 0.001), as well as a significant interaction 
effect for inhalant use × gender (η2 = 0.038, p < 0.001), 
explaining 6 and 4% of the variance in externalizing 
problems, respectively. The post hoc univariate effects for 
inhalant use in relation to externalizing problems were 
significant for all studied determinants, such as alcohol 
(η2 = 0.020, p < 0.001) and marijuana use (η2 = 0.088, 
p < 0.001), conduct problems (η2 = 0.039, p < 0.001), less 
severe (η2 = 0.154, p < 0.001) and severe delinquency 
(η2 = 0.091, p < 0.001). In addition, the post hoc univariate 
effect for alcohol-related problems (η2 = 0.062, p < 0.001) 
and substance use-related problems (η2 = 0.221, p < 0.001) 
in relation to inhalant use was also significant indicating 
higher problem levels with increased use of inhalants.
As the differences by inhalant use and gender could 
have been masked using a MANCOVA analysis (i.e. by 
simultaneously assessing all three outcomes in one model), 
we also attempted to examine each outcome separately to 
determine whether the patterns that were obtained from 
the MANCOVA analysis were also obtained for each out-
come individually. The results from the Uni ANCOVA 
were largely the same as those from the MANCOVA anal-
ysis (data not shown).
Discussion
The prevalence of inhalant use among adolescents in our 
study ranged from 3.4% among girls to 6.1% among boys. 
These figures are somewhat lower than those seen earlier 
in both English [20] and Russian language reports (e.g. 
data from the Ministry of Education, 2003). Although evi-
dence suggests that the prevalence rates of inhalant use in 
specific adolescent populations in Russia, such as street 
children [35], or juvenile delinquents [36], may be sub-
stantially higher, the discrepancy in rates between studies 
highlights the need for further research in this area.
The association observed between inhalant use and nega-
tive health and psychosocial effects is consistent with the 
results from studies in other countries [9–12, 14, 37]. As 
suggested earlier, inhalant users often experience academic 
problems which can include a scholastic decline [38] and 
which can sometimes lead to them dropping out of school 
altogether [39, 40]. In our study, inhalant users had lower 
academic motivation which indirectly supports the previ-
ously reported association between substance use and ado-
lescents’ poorer school achievements. Several studies have 
pointed to the possible bidirectionality of the association 
between low academic motivation and substance use [41]. 
Adolescents may use inhalants to cope with their concerns 
over academic failure and as a result lose their academic 
motivation [42, 43]. Alternatively, substance use may be a 
predisposing factor for difficulties at school, through reduced 
academic motivation [44] or because of substantial cognitive 
problems developing as a result of inhalant use [11].
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Consistent with earlier research [3], in the present study, 
inhalant use was also associated with depression and stress. 
It is possible that adolescents might use substances in an 
attempt to overcome negative moods and decrease perceived 
stress. The potential complexity and circularity of these rela-
tionships requires further research to elucidate these associa-
tions so that evidence-based interventions can be formulated 
to prevent adolescent depression and stress, and decrease 
risky behaviors.
While it is difficult to come to any direct conclusions 
about the clinical mental health needs of adolescents using 
inhalants in the present study, our findings nevertheless sug-
gest that the problem levels of these youth are significantly 
higher than those in the general population. The greater 
mental health needs of inhalant users in general are well 
documented, with some research even suggesting that inter-
nalizing psychopathology tends to increase along with the 
increasing frequency of inhalant use in this group [7]. Simi-
lar to those individuals with a clinical diagnosis of inhal-
ant abuse which is characterized by a substantial degree of 
functional impairment and of extensive comorbidity [45], 
the inhalant users in this study indicated a greater level of 
perceived functional impairment, associated with comorbid 
mental health problems.
Inhalant users in our study demonstrated a worrying pro-
file in terms of having a wide range of behavioral problems. 
Inhalant use was associated with more externalizing prob-
lems, and this association was much stronger compared to 
that with internalizing problems. Inhalants users were sig-
nificantly more likely to engage in delinquent behaviors, 
use other types of illegal substances and experience greater 
problems associated with substance use, as well as associ-
ate with delinquent peers. It is well documented that the 
above problems commonly co-occur [46, 47]. Inhalant users 
with behavioral problems may be especially vulnerable to 
the development of other types of psychopathology and of 
substance abuse [48, 49] with a high degree of comorbid-
ity between behavioural problems and substance use disor-
ders having been reported in several studies [46, 47]. This 
highlights the complexity of planning treatment efforts for 
inhalant users and the need to address a broad range of prob-
lems. In addition, it should also be remembered that not 
only engaging in juvenile delinquency strongly predisposes 
adolescents to use substances [50], including inhalants, but 
that chronic inhalant use creates an additional burden in 
terms of long-lasting sequela, such as increased cognitive 
impairment, problems with impulse control, and mental 
health problems [11, 12], which in turn increase the risk for 
repeated antisocial involvement.
The association observed between inhalant use and mari-
juana use and substance use-related problems is consistent 
with the findings from earlier studies [51]. As suggested pre-
viously [52, 53], compared with adolescents who use inhalants 
but who do not use marijuana, adolescents who use both sub-
stances have a particularly high rate of substance use disorders, 
including alcohol use disorders, and thus, represent a severe set 
of drug users, who require increased attention and multifaceted 
intervention efforts from health care providers and the school 
system alike.
The interaction effect for inhalant use by gender was not 
significant for anxiety and depression in our study suggest-
ing a similar pattern of internalizing problems in relation to 
inhalant use among boys and girls. However, a gender-specific 
difference with regard to posttraumatic stress was observed, 
where stress levels were lower in non-using boys than in non-
using girls, whereas in users, the opposite result was observed. 
Although greater traumatization in inhalant users has been 
well documented in previous research [36], to our knowledge, 
higher posttraumatic stress in male users has not been reported 
previously. This finding can, however, be tentatively explained 
by the often much heavier use of inhalants in boys [54, 55], as 
those under the influence of substances are generally at greater 
risk for being exposed to trauma. The gender differences relat-
ing to inhalant use were most pronounced for externalizing 
problems. This finding may relate to the substantially higher 
prevalence rates of externalizing behaviors in male as com-
pared to female adolescents [56].
As demonstrated in earlier studies, inhalant use has a 
substantial effect on the presence of psychopathology in 
youth. Since many solvent abusers begin experimentation 
in the pre-teenage years, preventive educational programs 
are best begun in the primary school grades. Continuing 
efforts are needed to educate adolescents, parents, teach-
ers, physicians, service providers, and policy makers about 
the dangers and health risks of inhalant use [57]. Almost 
unequivocally, prevention is considered the most effective 
strategy and should be comprehensive, evidence- and com-
munity-based, involving not only users and family members, 
but also peers and schools. Our results highlight the need to 
identify inhalant use and its comorbid disorders as early as 
possible to facilitate timely interventions to enhance psy-
chosocial health. Since volatile substances are legally avail-
able, cheap, easy to find, and are highly addictive, inhalant 
use will continue until appropriate methods of prevention 
and intervention measures are devised. Inhalant use offers 
a distinct challenge to the health care provider, who needs 
to be made more aware of the prevalence of inhalant use in 
the populations they serve, commonly abused products, and 
the medical consequences of intoxication and habitual use.
Limitations
This study has several limitations that should be mentioned. 
First, our findings are based exclusively on adolescent self-
reports, which are subject to recall and reporting biases. 
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In addition, some information, such as the relatively low 
reported prevalence of inhalant use might have been due 
to underreporting because of the teachers’ presence in the 
classroom while the students completed the questionnaires. 
Second, as this study was cross-sectional causal links could 
not be established between any of the variables. Third, we 
also lacked information about the age of onset of inhalant 
use and on factors associated with the initiation of inhalant 
use, which may have further elucidated the relation between 
inhalant use and negative psychosocial outcomes. Fourth, 
the small number of inhalant users meant that it was not 
possible to examine the difference between frequent and 
occasional use. Finally, we had no information on other fac-
tors which might have been important for our results such 
as parental mental health and their substance/inhalant use.
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